The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine

Journal of Nutrition

Volumn 136, Issue 7, 2006, Pages 1862-1867

  Possemiers, Sam ^a   Bolca, Selin ^a   Grootaert, Charlotte ^a   Heyerick, Arne ^a   Decroos, Karel ^a   Dhooge, Willem ^b   De Keukeleire, Denis ^a   Rabot, Sylvie ^c   Verstraete, Willy ^a   Van De Wiele, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c CEMAGREF   (France)

Author keywords

8 prenylnaringenin; Hops; Intestinal bacteria; Phytoestrogens; SHIME

Indexed keywords

8 PRENYLNARINGENIN; ESTROGEN; HUMULUS LUPULUS EXTRACT; PHYTOESTROGEN; PRENYLFLAVONOID ISOXANTHOHUMOL; UNCLASSIFIED DRUG; XANTHOHUMOL;

ADULT; ARTICLE; BEER; BIOAVAILABILITY; BIOTRANSFORMATION; COLON; CONTROLLED STUDY; DEMETHYLATION; DIET; DIGESTION; FECES MICROFLORA; FEMALE; FOOD INTAKE; HOPS; HUMAN; HUMULUS LUPULUS; INTESTINE; INTESTINE FLORA; MICROBIAL IMMUNITY; NONHUMAN; NORMAL HUMAN; STOMACH;

HUMULUS LUPULUS;

EID: 33745670638     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.7.1862     Document Type: Article

References (34)

1. Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res. 200;17:845-69.
2. Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419-27.
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women - principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33.
4. Wagner JD, Anthony MS, Cline JM. Soy phytoestrogens: research on benefits and risks. Clin Obstet Gynecol. 2001;44:843-52.
5. Brzezinski A, Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol. 1999;85:47-51.
6. Gainford MC, Simmons C, Nguyen H, Verma S, Clemons M. A practical guide to the management of menopausal symptoms in breast cancer patients. Support Care Cancer. 2005;13:573-8.
7. MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J. A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer. 2005;41:708-14.
8. Koch W, Heim G. Estrogens in hops and beer; preliminary report. Munch Med Wochenschr. 1953;95:845.
9. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab. 1999;84:2249-52.
10. Effenberger KE, Johnsen SA, Monroe DG, Spelsberg TC, Westendorf JJ. Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J Steroid Biochem Mol Biol. 2005;96:387-99.
11. Hümpel M, Isaksson P, Schaefer O, Kaufmanna U, Ciana P, Maggic A, Schleuning WD. Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J Steroid Biochem Mol Biol. 2005;97:299-305.
12. Diel P, Thomae RB, Caldarelli A, Zierau O, Kolba S, Schmidt S, Schwab P, Metz P, Vollmer G. Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats. Planta Med. 2004;70:39-44.
13. Pepper MS, Hazel SJ, Humpel M, Schleuning WD. 8-Prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. J Cell Physiol. 2004;199:98-107.
14. Zierau O, Morrissey C, Watson RWG, Schwab P, Kolba S, Metz P, Vollmer G. Antiandrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl) naringenin and 8-prenylnaringenin. Planta Med. 2003;69:856-8.
15. Coldham NG, Sauer MJ. Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem Toxicol. 2001;39:1211-24.
16. Simons AL, Renouf M, Hendrich S, Murphy PA. Human gut microbial degradation of flavonoids: structure-function relationships. J Agric Food Chem. 2005;53:4258-63.
17. Rowland I, Wiseman H, Sanders T, Adlercreutz H, Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans. 1999;27:304-8.
18. Stevens JF, Taylor AW, Deinzer ML. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography tandem mass spectrometry. J Chromatogr A. 1999;832:97-107.
19. Schaefer O, Bohlmann R, Schleuning WD, Schulze-Forster K, Humpel M. Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices. J Agric Food Chem. 2005;53:2881-9.
20. Possemiers S, Heyerick A, Robbens V, De Keukeleire D, Verstraete W. Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem. 2005;53:6281-8.
21. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow-dose micronized 17 beta-estradiol and bone density and bone metabolism in older women - a randomized controlled trial. JAMA. 2003;290:1042-8.
22. Molly K, Woestyne MV, Verstraete W. Development of a 5-step multichamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol. 1993;39:254-8.
23. Possemiers S, Verthé K, Uyttendaele S, Verstraete W. PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol. 2004;49:495-507.
24. Stevens JF, Ivancic M, Hsu VL, Deinzer ML. Prenylflavonoids from Humulus lupulus. Phytochemistry. 1997;44:1575-85.
25. Routledge EJ, Sumpter JP. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem. 1996;15:241-8.
26. De Boever P, Demare W, Vanderperren E, Cooreman K, Bossier P, Verstraete W. Optimization of a yeast estrogen screen and its applicability to study the release of estrogenic isoflavones from a soygerm powder. Environ Health Perspect. 2001;109:691-7.
27. Nollet L, VandeVelde I, Verstraete W. Effect of the addition of Pepto-streptococcus productus ATCC35244 on the gastro-intestinal microbiota and its activity, as simulated in an in vitro simulator of the human gastro-intestinal tract. Appl Microbiol Biotechnol. 1997;48:99-104.
28. Boon N, Top EM, Verstraete W, Siciliano SD. Bioaugmentation as a tool to protect the structure and function of an activated-sludge microbial community against a 3-chloroaniline shock load. Appl Environ Microbiol. 2003;69:1511-20.
29. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004;97:1166-77.
30. Spencer JPE. Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr. 2003;133:3255S-61.
31. Nikolic D, Li Y, Chadwick LR, Pauli GF, van Breemen RB. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J Mass Spectrom. 2005;40:289-99.
32. De Boever P, Deplancke B, Verstraete W. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J Nutr. 2000;130:2599-606.
33. Cummings JH. The large intestine in health and disease. Brussels: Institut Danone; 1997.
34. Diekert G, Wohlfarth G. Metabolism of homoacetogens. Antonie Van Leeuwenhoek. 1994;66:209-21.